
New Treatments for Cardiac Amyloidosis Emerging, but Timely Diagnosis Remains Essential to Improving Outcomes
In our latest Clinician’s View, Marcos Hazday, MD, FACC, director of the hypertrophic cardiomyopathy program at AdventHealth Orlando, discusses the new cardiac amyloidosis therapeutics available...